🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was granted for revolutionary findings that illuminate how the immune system attacks harmful pathogens while sparing the body's own cells.

A trio of esteemed researchers—from Japan Prof. Sakaguchi and American scientists Mary Brunkow and Fred Ramsdell—received this accolade.

The research identified specialized "sentinels" within the immune system that remove malfunctioning defense cells capable of attacking the body.

The findings are now paving the way for innovative treatments for autoimmune diseases and cancer.

These winners will share a monetary award worth 11m Swedish kronor.

Decisive Discoveries

"The research has been essential for comprehending how the immune system functions and the reason we don't all suffer from severe autoimmune diseases," commented the head of the award panel.

The team's studies address a fundamental question: In what way does the immune system protect us from countless invaders while leaving our healthy cells intact?

The body's protection system employs immune cells that scan for signs of disease, including pathogens and germs it has not met before.

These cells utilize sensors—called receptors—that are produced randomly in a vast number of combinations.

That provides the immune system the capacity to fight a broad range of invaders, but the unpredictability of the process unavoidably produces white blood cells that may target the host.

Security Guards of the Immune System

Researchers earlier understood that a portion of these problematic white blood cells were eliminated in the thymus—where white blood cells develop.

The latest award honors the discovery of regulatory T-cells—known as the body's "security guards"—which patrol the system to neutralize any defenders that attack the body's own tissues.

We know that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and RA.

A Nobel panel added, "The findings have established a novel area of investigation and accelerated the creation of innovative treatments, for instance for cancer and autoimmune diseases."

Regarding cancer, regulatory T-cells block the system from attacking the tumor, so studies are focused on reducing their quantity.

For self-attack disorders, experiments are exploring boosting regulatory T-cells so the body is not being harmed. A comparable approach could also be useful in minimizing the risks of organ transplant failure.

Pioneering Experiments

Professor Sakaguchi, from a Japanese institution, conducted experiments on mice that had their thymus removed, leading to self-attack conditions.

The researcher showed that injecting defense cells from other animals could stop the disease—suggesting there was a mechanism for preventing immune cells from harming the host.

Mary Brunkow, from the a research center in a US city, and Fred Ramsdell, currently at a biotech firm in San Francisco, were studying an genetic autoimmune disease in rodents and humans that resulted in the discovery of a genetic factor vital for the way regulatory T-cells function.

"Their pioneering work has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly targeting the body's own tissues," commented a prominent physiology specialist.

"This research is a remarkable example of how fundamental biological study can have far-reaching consequences for public health."